Integrative bioinformatics analysis identifies placental senescence-associated signatures in early-onset preeclampsia - Report - MDSpire

Integrative bioinformatics analysis identifies placental senescence-associated signatures in early-onset preeclampsia

  • By

  • Li Lin

  • Ying Chen

  • Lei Chen

  • Shengyi Gu

  • Yao Lai

  • Xiang Li

  • Jing Peng

  • Xiaolin Hua

  • July 8, 2026

  • 0 min

Share

Clinical Report: Bioinformatics Integration Reveals Senescence-Related Gene Signatures in Early-Onset Preeclampsia

Overview

This study identifies 44 senescence-related differentially expressed genes in early-onset preeclampsia (EOPE) placentas. Key hub genes, including LEP, ENG, MIF, and CYBB, are predominantly expressed in trophoblasts and immune cells.

Background

Early-onset preeclampsia (EOPE) is a severe hypertensive disorder of pregnancy that poses significant risks for maternal and fetal health. The role of placental senescence in EOPE pathogenesis has been increasingly recognized, yet the specific gene signatures involved remain poorly defined.

Data Highlights

GeneExpression Pattern
LEPPredominantly expressed in trophoblasts
ENGPredominantly expressed in immune cells
MIFHub gene identified in EOPE
CYBBHub gene identified in EOPE

Key Findings

  • A total of 44 senescence-related differentially expressed genes were identified in EOPE placentas.
  • These genes are mainly enriched in cell proliferation-related pathways.
  • LEP, ENG, MIF, and CYBB were identified as hub genes in the study.
  • Senescence-associated activity was primarily enriched in the trophoblast lineage.
  • LEP is implicated in syncytiotrophoblast senescence and secretory dysfunction.

Clinical Implications

Understanding the role of these genes in placental dysfunction could provide insights into the mechanisms of EOPE.

Conclusion

The findings indicate a relationship between placental senescence and early-onset preeclampsia, warranting further investigation into the molecular mechanisms involved.

Related Resources & Content

  1. BMC Pregnancy and Childbirth, 2023 -- Altered Notch pathway-related protein expression in cord blood of preeclampsia offspring: a pilot study
  2. BMC Pregnancy and Childbirth, 2023 -- Identifying biomarkers of the serum proteins and metabolites associated with severe preeclampsia
  3. BMC Pregnancy and Childbirth, 2023 -- Urinary transcription factor 21 (TCF21) as a non-invasive biomarker of podocyte injury in preeclampsia: diagnostic performance and translational insights from a case–control study
  4. BMC Pregnancy and Childbirth, 2023 -- Association between urinary neutrophil gelatinase-associated lipocalin and severe preeclampsia among pregnant women in Kinshasa: a multicenter-based cross-sectional study
  5. Late vs. Early Preeclampsia - PubMed, 2023
  6. ACOG Clinical Practice Update: Biomarker Prediction of Preeclampsia With Severe Features - SMFM Publications and Clinical Guidelines, 2023
  7. Early-onset preeclampsia: Current guidance and management
  8. ACOG Clinical Practice Update: Biomarker Prediction of Preeclampsia With Severe Features - SMFM Publications and Clinical Guidelines
  9. Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce

Original Source(s)

Related Content